Quest Diagnostics (DGX) Free Cash Flow (2009 - 2026)

Quest Diagnostics has disclosed Free Cash Flow across 18 years of filings, most recently posting $459.0 million for Q2 2026.

• In Q2 2026, Free Cash Flow rose 5.28% year-over-year to $459.0 million; the TTM figure through Jun 2026 stood at $1.3 billion (up 10.21% YoY), while the FY2025 annual figure was $1.4 billion, up 49.5% from the prior year.
• Free Cash Flow came in at $459.0 million for Q2 2026 at Quest Diagnostics, up from $164.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $459.0 million in Q2 2026 to a low of -$33.0 million in Q1 2023.
• Average Free Cash Flow over 5 years is $281.6 million, with a median of $316.5 million recorded in 2022.
• Year-over-year, Free Cash Flow tumbled 107.91% in 2023 and surged 294.0% in 2025.
• Over 5 years, Free Cash Flow stood at $187.0 million in 2022, then jumped by 143.32% to $455.0 million in 2023, then slipped by 25.05% to $341.0 million in 2024, then dropped by 9.97% to $307.0 million in 2025, then soared by 49.51% to $459.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $459.0 million in Q2 2026, $164.0 million in Q1 2026, and $307.0 million in Q4 2025.